Key Highlights
- Chemring Group (LSE:CHG) rose 3.75% to 539.50p on Friday 16 October 2026, among the strongest FTSE 250 gainers.
- Defence led a rotation into defensive sectors in London, with BAE Systems up 2.6% and Babcock up 3.6%.
- On 14 October Chemring's Roke subsidiary signed a five-year agreement worth at least $170m with a major US defence contractor.
- The deal covers Roke's Nav-Sync Miniature Radar Altimeter, with an initial $16m production order and deliveries starting in October 2026.
- Chief executive Michael Ord cited progress in Roke's international business despite near-term headwinds in the UK defence market.
Why Chemring Is Trending Today
Chemring Group (LSE:CHG) was one of the standout names in the FTSE 250 on Friday 16 October 2026, climbing 3.75% to close at 539.50p. The rise came as defence stocks led a broad rally in defensive sectors, with no new company announcement on the day.
The London market had a strong week. The FTSE 100 gained 0.38% to 10,881.90 on Friday, capping a 3.1% weekly rise and its best week in roughly six months, while the FTSE 250 added 0.45% to 24,533.90. After a global sell-off in AI and semiconductor stocks, investors moved money into sectors with more predictable demand, and defence was a clear beneficiary. Larger peers BAE Systems and Babcock International rose 2.6% and 3.6% respectively. Middle East tensions, with Brent crude trading near $105 a barrel and disruption in the Strait of Hormuz, reinforced expectations that military budgets will remain elevated.
For Chemring, the sector tailwind came on top of company-specific good news earlier in the week, which helped the shares push above the 521p level they reached on Wednesday.
The Roke Contract Win
On Wednesday 14 October, Chemring announced that its subsidiary Roke had signed a five-year strategic agreement with an unnamed major US defence contractor, worth at least $170m. The agreement covers the supply of Roke's Nav-Sync Miniature Radar Altimeter, a device designed for high-speed platforms and uncrewed air vehicles that measures altitude over land and sea. The relationship is expected to continue beyond the initial term, potentially to at least 2035.
Roke has already received an initial $16m production order covering the first 12 months, with deliveries due to begin in October 2026. Chemring said the altimeter combines a compact design and integrated antenna with Roke's proprietary software algorithms and digital signal-processing hardware. The shares rose as much as 4% on the day of the announcement.
Chief executive Michael Ord described the deal as another step in growing Roke's defence revenue, highlighting progress in its international business despite near-term headwinds in the UK defence market. That comment is notable: it suggests that Chemring (LSE:CHG) sees US and international demand helping to offset slower UK procurement.
Business Overview
Chemring operates through two main areas: Sensors and Information, which includes Roke's electronic warfare, cyber and sensing capabilities, and Countermeasures and Energetics, which makes aircraft countermeasures such as flares, as well as propellants, explosives and other energetic materials used in munitions and space systems. Energetics capacity has been in high demand since the war in Ukraine exposed shortages of munitions across NATO.
The company has reported a record order book in recent periods as countries rebuild stockpiles. It has also attracted takeover interest in the past, with private equity firm Bain Capital approaching the group in early 2025, underlining the strategic value of its assets.
Analyst View
Brokers continue to follow the stock closely. Jefferies reaffirmed a buy rating on Chemring around 15 October, while Berenberg lowered its price target around the same time, based on published analyst rating changes. The mixed signals reflect a debate over valuation and the pace of UK defence spending, set against strong international demand and a robust order book. Even so, the strength of Friday's move suggests investors in Chemring Group (LSE:CHG) are focusing on the long-term structural growth story.
Risks and What Investors Are Watching Next
The key near-term question is the UK. Management has flagged near-term headwinds in the UK defence market, and the Budget on Wednesday 28 October 2026 will be watched for any changes to the timing of defence spending increases. Execution risk in expanding energetics capacity and the possibility of contract delays also remain.
Chemring's financial year ends in October, and investors will look to its full-year trading update and results for detail on order intake, the order book, margins and Roke's international growth. Further contract announcements, particularly from the US and Europe, would help support the shares. Geopolitical developments will continue to drive sentiment across the FTSE 250 defence names, and Chemring (LSE:CHG) remains one of the most direct mid-cap plays on munitions and electronic warfare demand.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...